share_log

广济药业:北京市京师(武汉)律师事务所关于湖北广济药业股份有限公司回购注销2021年限制性股票激励计划部分限制性股票之法律意见书

Hubei Guangji Pharmaceutical: Legal Opinion of Beijing Jingshi (Wuhan) Law Firm on the Repurchase and Cancellation of Part of the Restricted Stock Incentive Plan of Hubei Guangji Pharmaceutical Co., Ltd. in the 2021 Restricted Stock Incentive Plan

SZSI ·  May 29
Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more